| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/20/2005 | EP1553920A1 Topical formulation for prevention and treatment of acne |
| 07/20/2005 | EP1401467A4 Alpha-fetoprotein peptides and uses thereof |
| 07/20/2005 | EP1392670B1 Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives |
| 07/20/2005 | EP1381606B1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 07/20/2005 | EP1303512B1 Process for preparing arylacetylaminothiazoles |
| 07/20/2005 | EP1286673B8 Ligands of integrin receptors |
| 07/20/2005 | EP1284959B1 Compounds for modulating the rage receptor |
| 07/20/2005 | EP1272484B1 Benzoamide piperidine compounds as substance p antagonists |
| 07/20/2005 | EP1261328B1 Il-8 receptor antagonists |
| 07/20/2005 | EP1189583B1 Indole derivatives |
| 07/20/2005 | EP1175402B1 Piperidine derivatives useful as ccr5 antagonists |
| 07/20/2005 | EP1175401B1 Piperazine derivatives useful as ccr5 antagonists |
| 07/20/2005 | EP1129077B9 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors |
| 07/20/2005 | EP1001759B1 Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |
| 07/20/2005 | EP0977586B1 Combinations of antigen and mucosal binding component for inducing specific immunological tolerance |
| 07/20/2005 | EP0910571B1 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 07/20/2005 | EP0901372B1 Potassium, sodium and tris oxaprozin salt pharmaceutical formulations |
| 07/20/2005 | EP0784430B1 Method for reducing unwanted cellular adhesions |
| 07/20/2005 | CN1643138A Novel cytokine ZCYTOR17 ligand |
| 07/20/2005 | CN1642983A Antibodies against of C5aR and use thereof |
| 07/20/2005 | CN1642980A Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 07/20/2005 | CN1642971A A nucleic acid encoding a G-protein-coupled receptor, and uses thereof |
| 07/20/2005 | CN1642966A Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a |
| 07/20/2005 | CN1642955A Novel alkoxypyridine-derivatives |
| 07/20/2005 | CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642944A (3Z) -3-(2, 3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 07/20/2005 | CN1642943A Synthesis of piperidine and piperazine compounds as CCR5 antagonists |
| 07/20/2005 | CN1642929A Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| 07/20/2005 | CN1642926A Crystalline parecoxib sodium |
| 07/20/2005 | CN1642918A Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine |
| 07/20/2005 | CN1642913A Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially CCR5) |
| 07/20/2005 | CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642902A Polyamine compounds and compositions for use in conjunction with cancer therapy |
| 07/20/2005 | CN1642600A 1, 2-dihydropyrazol-3-ones which controls inflammatory cytokines |
| 07/20/2005 | CN1642577A Preparation comprising buprenorphine |
| 07/20/2005 | CN1642573A Combination of an aldosterone receptor antagonist and a fibric acid derivative |
| 07/20/2005 | CN1642567A HIV inhibiting proteins |
| 07/20/2005 | CN1642563A Compositions and methods for treatment of skin disorders |
| 07/20/2005 | CN1642556A Combination of an aldosterone receptor antagonist and a bile acid sequestering agent |
| 07/20/2005 | CN1642554A Benzenesulphonate salt of a morpholine urea derivative for use as a CCR-3 antagonist in the treatment of inflammatory conditions |
| 07/20/2005 | CN1642553A N-{'(2S) -4- (3, 4-difluorobenzyl) morpholin-2yl!methyl} -2-{3-' (methylsulphonyl) amino! phenyl}acetamide as CCR3 antagonist for the treatment of inflammatory conditions |
| 07/20/2005 | CN1642551A Inhibitors of histone deacetylase |
| 07/20/2005 | CN1642550A Beta-sheet mimetics and composition and methods relating thereto |
| 07/20/2005 | CN1642549A Pharmaceutical compositions comprising 2-(4-ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo'1, 5-bipyridazine in nanoparticulate form |
| 07/20/2005 | CN1642542A Angiogenesis inhibitors |
| 07/20/2005 | CN1642539A Diclofenac sodium oral pharmaceutical |
| 07/20/2005 | CN1642537A Ibuprofen solution for hard shell capsules |
| 07/20/2005 | CN1642528A Stable salts of O-acetylsalicylic acid containing basic amino acids II |
| 07/20/2005 | CN1640870A Ibuprofen ester, medically-acceptable salt, and its preparing process and medicinal composition |
| 07/20/2005 | CN1640472A Chinesle herbal medicine liquor |
| 07/20/2005 | CN1640467A Method for preparing compound corydalis amabilis preparation |
| 07/20/2005 | CN1640458A Navel-moistening health-care liquor |
| 07/20/2005 | CN1640456A Chinese medicine for treating chronic pelvic inflammation and its preparing process |
| 07/20/2005 | CN1640452A Use of manchurian tuber gourd fruit extract for preparing analgesic, anti-inflammatory and/or anti-allergic medicine |
| 07/20/2005 | CN1640420A Strong-effect pain-removing liquor |
| 07/20/2005 | CN1211383C Process for making substituted 8-arylquinolinium benzenesulfonate |
| 07/20/2005 | CN1211381C Substituted imidazoles useful in treatment of inflammatory diseases |
| 07/20/2005 | CN1211373C 2,d-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 07/20/2005 | CN1211126C Vascular endothelial growth factor 2 |
| 07/20/2005 | CN1211125C Olopatadine formulations for topical administration |
| 07/20/2005 | CN1211123C Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| 07/20/2005 | CN1211117C Preparation of Xinxue granules |
| 07/20/2005 | CN1211104C Chinese medicine wine for treating rheumatism and arthralgia |
| 07/20/2005 | CN1211103C Oral taken and external use medicine for antirheumatism and stopping numbness pain and preparation method |
| 07/20/2005 | CN1211089C Application of uridine phosphorylase inhibitor and composition containing the same |
| 07/20/2005 | CN1211085C Compositions having improved stability |
| 07/20/2005 | CN1211083C Sophoridine and its application in analgesic |
| 07/20/2005 | CN1211072C Snake wine |
| 07/20/2005 | CN1211063C Compositions comprising organosiloxane resins for delivering oral care substances |
| 07/19/2005 | US6919470 Aryl and heteroaryl sulfonates |
| 07/19/2005 | US6919455 4-((9-((3-Cyclopentyloxy-4-methoxy)benzyl)-6,8 dimethylpurin)-2-yl-3-oxypropyl)pyridine N-oxide chemical intermediate; phosphodiesterase inhibitors; antiasthmatic and antiinflammatory agents; chronic obstructive pulmonary disease |
| 07/19/2005 | US6919377 Cyclohexylamine derivative as subtype selective NMDA receptor antagonists |
| 07/19/2005 | US6919361 Five-membered-ring compound |
| 07/19/2005 | US6919355 Amide derivatives as NMDA receptor antagonists |
| 07/19/2005 | US6919353 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 07/19/2005 | US6919349 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 07/19/2005 | US6919347 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens |
| 07/19/2005 | US6919346 Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity |
| 07/19/2005 | US6919345 Sulfonate substituted pyrazol pyridine derivatives |
| 07/19/2005 | US6919344 Heterocyclic amines such as N-(Pyridin-4-yl)-(1-(4-fluoro-benzyl)indol-3-yl)glyoxylamide, used for prophylaxis of skin disorders, rheumatic diseases or arthritis |
| 07/19/2005 | US6919343 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives |
| 07/19/2005 | US6919340 Kinase moderators; controlling gene expression; immunosuppressants; autoimmune disease; rheumatic disorders; skin disorders; antitumor agents; anticancer agents |
| 07/19/2005 | US6919335 Heterocycles that are inhibitors of IMPDH enzyme |
| 07/19/2005 | US6919332 Enzyme inhibitors such as 5-(2-Methoxy-ethyl)-5-(4-(1-pyridin -3-yl-1H-indazol-5-yloxy)-phenoxy)-pyrimidine-2,4,6-trione, used as antiinflammatory and anticarcinogenic agents |
| 07/19/2005 | US6919307 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 07/14/2005 | WO2005063725A1 Phenylpropanoic acid derivatives |
| 07/14/2005 | WO2005063283A1 Vaccine comprising recombinant clpp protein of streptococcus pneumoniae |
| 07/14/2005 | WO2005009480A3 Implants containing codrugs |
| 07/14/2005 | WO2004000016A9 Antimicrobial compositions, products and methods employing same |
| 07/14/2005 | WO2003059294A3 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 07/14/2005 | US20050155089 Transport protein for use in identifying modulators for prevention and treatment of inflammation, cardiovascular, neurological, reproductive and developmental disorders |
| 07/14/2005 | US20050154230 Urea derivatives |
| 07/14/2005 | US20050154190 compounds obtained by the screening of the present invention are useful as agents for the prevention/treatment of, for example, neurodegenerative diseases, immunological diseases, edema, acid indigestion, etc. |
| 07/14/2005 | US20050154165 Ph-sensitive polymer |
| 07/14/2005 | US20050154044 Substituted tetrahydrocarbazole and cyclopentanoindole derivatives |
| 07/14/2005 | US20050154039 5-Sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine |
| 07/14/2005 | US20050154028 1-(3-Fluoro-phenyl)-3-[4-methoxy-3-(2-piperidin-1-yl-ethoxy)-phenyl]-imidazolidin-2-one; serotonin 5-ht2c receptor antagonist; antidepressant and anxiolytic agent |
| 07/14/2005 | US20050154026 Suitable for the treatment of gastric and intestinal disorders; in particular, omeprazole, rabeprazole, pantoprazole, esomeprazole |
| 07/14/2005 | US20050154025 6-[4-(fluoro- or trifluoromethyl)pyridyl-4-(p-fluorophenyl)-5-methylimidazol-2-yl] pyridones; cyclization of 1-phenyl-1-pyridyl-1,2-diaminopropanes with an acid, amidine, or nitrile compound; neuropeptide Y receptor antagonists; cardiovascular and central nervous system disorders, metabolic diseases |